右心室节奏的有效性对症状左心室中腔阻塞的症状
Sou Takenaka1, Akihiko Ueno1, Daisuke Iida1
1Department of Cardiology IMS Katsushika Heart Center Tokyo Japan.
Journal of arrhythmia
|December 4, 2023
概括
右心室节奏改善了左心室压力梯度和心力衰竭症状. 一些患者立即出现改善,而另一些患者则在一年后出现改善,表明节奏节奏.
科学领域:
- 心脏病学 心脏病学
- 心脏电生理学 心脏电生理学
- 心脏衰竭病理生理学 病理生理学
背景情况:
- 室内压力梯度 (IVPGs) 可以显著影响左心室功能,并导致心力衰竭症状.
- 右心室节拍是一种常见的干预措施,但它对IVPG及其相关症状的具体影响需要进一步阐明.
研究的目的:
- 为了研究左心室内心室内压力梯度 (IVPGs) 和纽约心脏协会 (NYHA) 功能分类的连续变化.
- 评估右心室节拍在改善IVPG和改善心力衰竭患者的临床状况方面的有效性.
主要方法:
- 左心室内心室内压力梯度的连续评估.
- 对NYHA功能分类的监控.
- 在启动右心室节拍后对变化的评估.
主要成果:
- 右心室节奏导致左心室内压力梯度和NYHA功能分类的改善.
- 在一名患者中,IVPG在节奏调节后立即消失.
- 在其他患者中,IVPG解决发生在慢性阶段,延长超过一年.
结论:
- 右心室节奏是改善左心室内心室压梯度和心力衰竭症状的有效策略.
- 治疗IVPG的时间可能会有所不同,有些患者会立即获得好处,而另一些患者则会出现延迟的改善.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


